Although prophecy in science is extremely dangerous no great progress in xe
notransplantation may be expected in the next ten years. In contrast introd
uction of less dangerous immunosuppressive strategies and induction of tran
splant-specific tolerance seems likely. Thanks to better prophylaxis and th
erapy a declining incidence of endstage renal failure due to diabetic and h
ypertensive nephropathy respectively can be expected. Progress in the field
of fibroblast pathophysiology will be followed by improvement of therapy o
f fibrotizing nephropathies. Genetherapy will be available for the treatmen
t of selective congenital and acquired nephropathies, although unexpected a
dverse effects of these new therapeutic strategies may emerge. Finally than
ks to progresses in renal pathophysiology, better therapeutic results may b
e expected in the treatment of disease caused by abnormalities of the homeo
static role of the kidneys.